Technological Advancement in Genotyping to Boost Market Growth

26 March 2020: Genotyping is a technique used to detect genetic alteration in the allelic genes or genomic sequence of an individual by associating it against the reference sequence. It assists to explore genetic variants including single nucleotide polymorphism (SNPs) and structural changes in DNA.

The emerging trend in the market is technological advancement of including chips that adjust 1 million SNP assays and other developments that resulted in identification of numerous novel genes for the common diseases.

Reagents and Kits Segment to Contribute Significant Demand to the Market

The major product variants of the genotyping market include services, reagents and kits, and instruments. The reagents and kits sector accounted for the fastest growing sector in the market and is anticipated to expand at a CAGR of 23.0% over the forthcoming period. 

The factors that attribute to the growth of genotyping industry include extensive usage rate and constantly increasing demand for the genotyping tests. The easy availability and cost-effectiveness of the reagents are anticipated to significantly influence the market growth in the forecast period.

In addition, the presence of favorable funding programs and extensive application in the R&D laboratories are expected to further propel the reagents and kits segment in the years to come. Reagents, such as enzymes, buffers, and assays are extensively used for PCR cleanup, cellular manipulation, and DNA sequencing. The introduction of new reagents, such as SBE and ExoSAP-IT PCR products, and PCR cleanup reagents by Affymetrix, Inc., is also expected to observe a high acceptance rate over the forecast period.

Market Insights

Mergers, acquisitions, and collaborations are the key market strategies undertaken by the companies to support their global presence. For example, in December 2015, Thermo Fisher, Inc. purchased Life Technologies Corporation with the purpose of growing its product portfolio for the genotyping industry. 

In April 2016, a strategic collaboration was announced by Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc. for the growth of an innovative and integrated genotyping platform. This contract is expected to present improved customizability and flexibility to their molecular testing solutions.

Leading players operating in the genotyping market include Agilent Technologies, Inc; Affymetrix, Inc.; Fluidigm Corporation; Genewiz, Inc.; Illumina, Inc.; GE Healthcare GmbH; Qiagen NV; Roche Diagnostics; and Thermo Fisher Scientific, Inc.